Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
King Legacy is recalling Levoxyl tablets that were below specification for potency at the expiry stability point.
Lloyd Inc. of Iowa is recalling Levothroid tablets due to cGMP deviations and stability failures in previous lots.
Lloyd Inc. of Iowa is recalling 7.6 million Thyro-Tab tablets due to cGMP deviations and stability failures. The product was distributed nationwide and to Puerto Rico.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab 0.088 mg tablets due to cGMP deviations and stability failures. The product was repackaged by Forest Laboratories and distributed nationwide.
Lloyd Inc. of Iowa is recalling 9.5 million Thyro-Tab tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling Levothroid tablets due to cGMP deviations and insufficient stability data. The recall affects 12,156 bottles distributed nationwide and to Puerto Rico.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
King Legacy is recalling Levoxyl (levothyroxine sodium) tablets because they were below specification for potency at the expiry stability point.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
Lloyd Inc. of Iowa is recalling 4,440 bottles of Levothroid 50 mcg tablets due to cGMP deviations and stability failures in previous lots.
Lloyd Inc. of Iowa is recalling specific lots of Levothroid tablets due to stability failures and insufficient data to rule out other affected lots.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
King Legacy is recalling Levoxyl tablets because they were below specification for potency at the expiry stability point.
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium) tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling 3.8 million Thyro-Tab tablets due to cGMP deviations and insufficient stability data.
Lloyd Inc. of Iowa is recalling bulk Thyro-Tab tablets due to cGMP deviations and stability failures. The product was repackaged and distributed nationwide.
Mylan Institutional, Inc. is recalling 1,621 boxes of Budesonide Capsules, 3 mg, because routine stability testing showed out-of-specification dissolution results.
Aaron Industries is recalling Rite Aid brand Tussin Cough & Cold Mucus Relief CF due to the presence of white precipitate, identified as the active ingredient guaifenesin.
Novartis Consumer Health is recalling 3,828 tubes of Lamisil AT antifungal cream because the lot and expiration dates may be illegible.
Green Valley Drugs is recalling Cyanocobalamin 1000 mcg/mL injection because testing revealed positive sterility results.
Performance Plus Marketing is recalling BLUE Diamond Platinum Capsules because they may contain undeclared sildenafil, tadalafil, and analogues, making them unapproved drugs.
Performance Plus Marketing is recalling Mojo Nights Capsules because they may contain undeclared sildenafil, tadalafil, and analogues, making them unapproved drugs.